Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Mottok

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Blood|September 8, 2009
Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entitiesAnja Mottok, Christoph Renné, Marc Seifert, et al.
Plos One|December 19, 2013
Non-invasive bioluminescence imaging to monitor the immunological control of a plasmablastic lymphoma-like B cell neoplasia after hematopoietic cell transplantationMartin Chopra, Sabrina Kraus, Stefanie Schwinn, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2015
Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activityMartin Vaeth, Carina A Bäuerlein, Tobias Pusch, et al.
Blood|December 15, 2010
Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survivalTorsten Steinbrunn, Thorsten Stühmer, Stefan Gattenlöhner, et al.
The Journal of Pathology|July 20, 2017
Monoamine oxidase A is highly expressed in classical Hodgkin lymphomaPei Chuan Li, Imran N Siddiqi, Anja Mottok, et al.
Clinical Nuclear Medicine|December 5, 2013
Three-phase bone scintigraphy for imaging osteoradionecrosis of the jawConstantin Lapa, Christian Linz, Christina Bluemel, et al.
Annals of Hematology|February 12, 2021
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patternsSophia Danhof, Leo Rasche, Anja Mottok, et al.
The American Journal of Surgical Pathology|November 2, 2020
A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell LymphomasHeike Horn, Sabrina Kalmbach, Rabea Wagener, et al.
British Journal of Haematology|April 29, 2014
PI3K-dependent multiple myeloma cell survival is mediated by the PIK3CA isoformClaudia Hofmann, Thorsten Stühmer, Nadine Schmiedl, et al.
Plos One|January 10, 2013
Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myelomaSimone S Riedel, Anja Mottok, Christian Brede, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Blood|September 8, 2009
Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entitiesAnja Mottok, Christoph Renné, Marc Seifert, et al.
Plos One|December 19, 2013
Non-invasive bioluminescence imaging to monitor the immunological control of a plasmablastic lymphoma-like B cell neoplasia after hematopoietic cell transplantationMartin Chopra, Sabrina Kraus, Stefanie Schwinn, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2015
Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activityMartin Vaeth, Carina A Bäuerlein, Tobias Pusch, et al.
Blood|December 15, 2010
Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survivalTorsten Steinbrunn, Thorsten Stühmer, Stefan Gattenlöhner, et al.
The Journal of Pathology|July 20, 2017
Monoamine oxidase A is highly expressed in classical Hodgkin lymphomaPei Chuan Li, Imran N Siddiqi, Anja Mottok, et al.
Clinical Nuclear Medicine|December 5, 2013
Three-phase bone scintigraphy for imaging osteoradionecrosis of the jawConstantin Lapa, Christian Linz, Christina Bluemel, et al.
Annals of Hematology|February 12, 2021
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patternsSophia Danhof, Leo Rasche, Anja Mottok, et al.
The American Journal of Surgical Pathology|November 2, 2020
A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell LymphomasHeike Horn, Sabrina Kalmbach, Rabea Wagener, et al.
British Journal of Haematology|April 29, 2014
PI3K-dependent multiple myeloma cell survival is mediated by the PIK3CA isoformClaudia Hofmann, Thorsten Stühmer, Nadine Schmiedl, et al.
Plos One|January 10, 2013
Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myelomaSimone S Riedel, Anja Mottok, Christian Brede, et al.
Pageof 9